glp 1 lr3 Triple GLP-1 / GIP / Glucagon Receptor Agonist (CAS 2381089-83-2) IGF-1 LR3 (1MG) : COA

Fluid accumulation may play a role in rapid weight gain and dyspnea in morbid obesity

10.1111/bph.15677

Common gastrointestinal side effects that are especially severe or do not resolve within a few weeks, such as nausea, diarrhea, constipation, or vomiting, are also common reasons for stopping the medication

192207 While concerns about potential muscle loss with GLP-1 RAs remain, recent evidence from the SEMALEAN study suggests this risk may be attenuated with semaglutide 2.4 mg

But many users, like Diaz, are experiencing an alarming boomerang effect once they go off the drug, gaining all their weight back and often, much more

doi:10.2147/DMSO.S312527 16